These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

246 related items for PubMed ID: 16034717

  • 1. Clinical and biochemical characterization of women with polycystic ovary syndrome in North Rhine-Westphalia.
    Hahn S, Tan S, Elsenbruch S, Quadbeck B, Herrmann BL, Mann K, Janssen OE.
    Horm Metab Res; 2005 Jul; 37(7):438-44. PubMed ID: 16034717
    [Abstract] [Full Text] [Related]

  • 2. Type 2 diabetes and the polycystic ovary syndrome.
    Pelusi B, Gambineri A, Pasquali R.
    Minerva Ginecol; 2004 Feb; 56(1):41-51. PubMed ID: 14973409
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Prevalence of the metabolic syndrome in German women with polycystic ovary syndrome.
    Hahn S, Tan S, Sack S, Kimmig R, Quadbeck B, Mann K, Janssen OE.
    Exp Clin Endocrinol Diabetes; 2007 Feb; 115(2):130-5. PubMed ID: 17318774
    [Abstract] [Full Text] [Related]

  • 6. Metabolic and cardiovascular consequences of polycystic ovary syndrome.
    Orio F, Vuolo L, Palomba S, Lombardi G, Colao A.
    Minerva Ginecol; 2008 Feb; 60(1):39-51. PubMed ID: 18277351
    [Abstract] [Full Text] [Related]

  • 7. Clinical and biochemical characteristics of polycystic ovary syndrome in Korean women.
    Chae SJ, Kim JJ, Choi YM, Hwang KR, Jee BC, Ku SY, Suh CS, Kim SH, Kim JG, Moon SY.
    Hum Reprod; 2008 Aug; 23(8):1924-31. PubMed ID: 18579512
    [Abstract] [Full Text] [Related]

  • 8. The evaluation of metabolic parameters and insulin sensitivity for a more robust diagnosis of the polycystic ovary syndrome.
    Amato MC, Galluzzo A, Finocchiaro S, Criscimanna A, Giordano C.
    Clin Endocrinol (Oxf); 2008 Jul; 69(1):52-60. PubMed ID: 18034780
    [Abstract] [Full Text] [Related]

  • 9. Chronic inflammation and elevated homocysteine levels are associated with increased body mass index in women with polycystic ovary syndrome.
    Guzelmeric K, Alkan N, Pirimoglu M, Unal O, Turan C.
    Gynecol Endocrinol; 2007 Sep; 23(9):505-10. PubMed ID: 17852421
    [Abstract] [Full Text] [Related]

  • 10. Insulin response to oral glucose in healthy, lean young women and patients with polycystic ovary syndrome.
    Kulshreshtha B, Ganie MA, Praveen EP, Gupta N, Lal Khurana M, Seith A, Dwivedi SN, Kumar G, Ammini AC.
    Gynecol Endocrinol; 2008 Nov; 24(11):637-43. PubMed ID: 19031221
    [Abstract] [Full Text] [Related]

  • 11. Effects of metformin and ethinyl estradiol-cyproterone acetate on clinical, endocrine and metabolic factors in women with polycystic ovary syndrome.
    Wu J, Zhu Y, Jiang Y, Cao Y.
    Gynecol Endocrinol; 2008 Jul; 24(7):392-8. PubMed ID: 18608522
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Clinical and metabolic characteristics of polycystic ovary syndrome without polycystic ovary: a pilot study on Chinese women.
    Shi Y, Gao X, Sun X, Zhang P, Chen Z.
    Fertil Steril; 2008 Oct; 90(4):1139-43. PubMed ID: 17889857
    [Abstract] [Full Text] [Related]

  • 14. The peroxisome proliferator activated receptor gamma Pro12Ala polymorphism is associated with a lower hirsutism score and increased insulin sensitivity in women with polycystic ovary syndrome.
    Hahn S, Fingerhut A, Khomtsiv U, Khomtsiv L, Tan S, Quadbeck B, Herrmann BL, Knebel B, Müller-Wieland D, Mann K, Janssen OE.
    Clin Endocrinol (Oxf); 2005 May; 62(5):573-9. PubMed ID: 15853827
    [Abstract] [Full Text] [Related]

  • 15. Association between the polycystic ovary syndrome and the metabolic syndrome in Puerto Rico.
    Rabelo Acevedo M, Vick MR.
    P R Health Sci J; 2005 Sep; 24(3):203-6. PubMed ID: 16329683
    [Abstract] [Full Text] [Related]

  • 16. Body fat composition and distribution in women with polycystic ovary syndrome.
    Cosar E, Uçok K, Akgün L, Köken G, Sahin FK, Arioz DT, Baş O.
    Gynecol Endocrinol; 2008 Aug; 24(8):428-32. PubMed ID: 18850379
    [Abstract] [Full Text] [Related]

  • 17. Polycystic ovary syndrome and type 2 diabetes mellitus.
    De Leo V, Musacchio MC, Morgante G, La Marca A, Petraglia F.
    Minerva Ginecol; 2004 Feb; 56(1):53-62. PubMed ID: 14973410
    [Abstract] [Full Text] [Related]

  • 18. [Effect of hyperprolactinemia upon clinical symptoms of patients with polycystic ovary syndrome].
    Wang Y, Hu ZP, Li MZ, Li R, Wang LN, Chen XN, Yang CS, Qiao J.
    Zhonghua Yi Xue Za Zhi; 2009 Oct 13; 89(37):2599-603. PubMed ID: 20137674
    [Abstract] [Full Text] [Related]

  • 19. [Exploration of the classification of polycystic ovarian syndrome].
    Lin JF, Li X, Zhu MW.
    Zhonghua Fu Chan Ke Za Zhi; 2006 Oct 13; 41(10):684-8. PubMed ID: 17199924
    [Abstract] [Full Text] [Related]

  • 20. An association between non-alcoholic fatty liver disease and polycystic ovarian syndrome.
    Brzozowska MM, Ostapowicz G, Weltman MD.
    J Gastroenterol Hepatol; 2009 Feb 13; 24(2):243-7. PubMed ID: 19215335
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.